Z Gastroenterol 2025; 63(08): e460
DOI: 10.1055/s-0045-1810786
Abstracts | DGVS/DGAV
Kurzvorträge
Immun gesteuert: Leberregeneration zwischen Inflammation und Regeneration Freitag, 19. September 2025, 10:05 – 11:41, Vortragsraum 11

Extracellular matrix protein 1 (ECM1) As a dual regulator of liver regeneration via HGF/c-MET and TGF-β signaling pathways

Y Yao
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
Y Li
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
A Friebel
2   University of Leipzig, Interdisciplinary Centre for Bioinformatics, Leipzig, Deutschland
,
C Huang
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
3   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Department of Clinical Laboratory Medicine Center, Shanghai, China
,
S Hammad
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
E Holstein
4   German Cancer Research Center, DKFZ, Heidelberg, Deutschland
,
L Danielczyk
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
R Liebe
5   Otto-von-Guericke-University, Clinic of Gastroenterology, Hepatology and Infectious Diseases, Magdeburg, Deutschland
,
C Gao
3   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Department of Clinical Laboratory Medicine Center, Shanghai, China
,
M Ebert
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
6   European Molecular Biology Laboratory, Molecular Medicine Partnership Unit, Heidelberg, Deutschland
7   DKFZ-Hector Cancer Institute at the University Medical Center, Mannheim, Deutschland
,
H Weng
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
U Klingmüller
4   German Cancer Research Center, DKFZ, Heidelberg, Deutschland
,
P ten Dijke
8   Leiden University Medical Center, Oncode Institute and Department of Cell and Chemical Biology, Leiden, Niederlande
,
S Höhme
2   University of Leipzig, Interdisciplinary Centre for Bioinformatics, Leipzig, Deutschland
,
S Dooley
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
,
S Wang
1   University Medical Center Mannheim, Department of Medicine II, Mannheim, Deutschland
› Institutsangaben
 

Introduction: Extracellular matrix protein 1 (ECM1) is crucial for liver homeostasis and negatively correlates with chronic liver disease progression. However, its role in acute liver injury and regeneration (LR) remains unclear.

Objective: This study investigates ECM1's impact on LR and its underlying mechanisms.

Methodology: Ecm1-tdTomato mice were administered adeno-associated virus 8 (AAV8)-ECM1 seven days before 70% partial hepatectomy (PHx). Hepatic gene expression was analyzed with RNA sequencing. Functional assays were done with hepatocytes, mouse liver tissue and patient samples.

Results: ECM1 is downregulated during LR after PHx. Interference with ECM1 downregulation by AAV8-ECM1 delays proliferation and liver mass gain at days 2 and 4, but catches up by day 8, as indicated by the liver-to-body weight ratio and immunostaining of BrdU and PCNA. Mechanistically, in early-stages of LR (days 0–4), downregulation of ECM1 is required for efficient HGF/c-MET/ERK/MYC signaling to mediate cell cycle progression, including CyclinA2, B1, B2, and Birc5 expression. In the late stage (days 4–8), overexpression of ECM1 inhibits latent TGF-β activation, therefore interfering with TGF-β-induced cell cycle kinase inhibitors p15, p16, p18, and p19, required for regeneration termination, which finally restores the liver mass. Additionally, Myc overexpression in hepatocytes rescues ECM1 mediated proliferation inhibition. In the liver of patients, ECM1-negative tissues display increased nuclear expression of MYC and PCNA.

Conclusion: ECM1 regulates liver regeneration by modulating HGF/c-MET/ERK/MYC and TGF-β/SMAD pathways. We hypothesize that for patients requiring liver regeneration, ECM1 downregulation benefits hepatocyte proliferation and liver function restoration. However, its inhibitory effect on TGF-β signaling should also be considered.



Publikationsverlauf

Artikel online veröffentlicht:
04. September 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany